The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Hematocrit and risk of venous thromboembolism in a general population. The Tromso study
Open accessAbstract
BACKGROUND: Hematocrit above the normal range for the population, such as in primary or secondary erythrocytosis, predisposes to both arterial and venous thrombosis. However, little is known about the association between hematocrit and risk of venous thromboembolism in a general population. DESIGN AND METHODS: Hematocrit and related hematologic variables such as hemoglobin, red blood cell count, mean corpuscular volume, and baseline characteristics were measured in 26,108 subjects, who participated in the Tromsø Study in 1994-1995. Incident venous thromboembolic events during follow-up were registered up to September 1(st), 2007. RESULTS: There were 447 venous thromboembolic events during a median of 12.5 years of follow-up. Multivariable hazard ratios per 5% increment of hematocrit for the total population, adjusted for age, body mass index and smoking, were 1.25 (95% CI: 1.08-1.44) for total venous thromboembolism and 1.37 (95% CI: 1.10-1.71) for unprovoked venous thromboembolism. In category-based analyses, men with a hematocrit in the upper 20(th) percentile (>or=46% in men) had a 1.5-fold increased risk of total venous thromboembolism (95% CI: 1.08-2.21) and a 2.4-fold increased risk of unprovoked venous thromboembolism (95% CI: 1.36-4.15) compared to men whose hematocrit was in the lower 40(th) percentile. The risk estimates were higher for men than for women both in continuous and category-based analyses. The findings for hemoglobin and red blood cell count were similar to those for hematocrit, whereas mean corpuscular volume was not associated with venous thromboembolism. Conclusions Our findings suggest that hematocrit and related hematologic variables such as hemoglobin and red blood cell count are risk factors for venous thromboembolism in a general population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Danesh, J. (2000) · European Heart Journal · doi:10.1053/euhj.1999.1699 · Cited by 339
Cited by
Klinefelter Syndrome: Integrating Genetics, Neuropsychology, and Endocrinology
Gravholt, C. H., Chang, S., Wallentin, M., Fedder, J., Moore, P., & Skakkebæk, A. (2018) · Endocrine Reviews · doi:10.1210/er.2017-00212 · Cited by 328
Erythrocytosis Following Testosterone Therapy
Ohlander, S. J., Varghese, B., & Pastuszak, A. W. (2018) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2017.04.001 · Cited by 168
YU, F. T. H., ARMSTRONG, J. K., TRIPETTE, J., MEISELMAN, H. J., & CLOUTIER, G. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.04164.x · Cited by 108
Testosterone replacement therapy: for whom, when and how?
Tsametis, C. P., & Isidori, A. M. (2018) · Metabolism · doi:10.1016/j.metabol.2018.03.007 · Cited by 96
Metadata
- Authors
- Braekkan, S. K., Mathiesen, E. B., Njolstad, I., Wilsgaard, T., & Hansen, J.-B.
- Venue
- Haematologica
- Published
- 2009-10-14
- Volume
- 95
- Issue
- 2
- Pages
- 270-275
- ISSN
- 0390-6078 (ISSN-L)
- 1592-8721
- OpenAlex
- W2124151873
- Cited by
- 206
- References
- 1
- FWCI
- 2.21
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hematocrit and risk of venous thromboembolism in a general population. The Tromso study. https://app.cochat.ai/papers/10.3324/haematol.2009.008417
- The paper
- Braekkan, S. K., Mathiesen, E. B., Njolstad, I., Wilsgaard, T., & Hansen, J.-B. (2010). Hematocrit and risk of venous thromboembolism in a general population. The Tromso study. Haematologica. https://doi.org/10.3324/haematol.2009.008417
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.